|
2008 WHO Diagnostic Algorithms for PV, ET, PMF, and atypical MPD/MPNs* utilize a comprehensive range of technologies offered by COMPASS™.
*MPD nomenclature now replaced by MPN (myeloproliferative neoplasms) per the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008;22(1):14-22.
A complete COMPASS work-up for suspected MPD/MPNs includes, as medically necessary:
- Reflex to all necessary tests for a comprehensive clinical picture and patient specific diagnosis using 2008 WHO guidelines.
- Molecular analyses by the first commercial lab to bring you MPL and quantitative JAK2
- Morphology by a highly trained hematopathologist
- Multi-color flow cytometry by a team with over 100 years combined experience
- Cytogenetics/FISH with a high metaphase culture success rate
One hematopathologist is responsible for your case, from start to finish.
Contact your Oncology Specialist today. Please call: 800.755.1605
CLICK HERE FOR eCOMPASS
|
